Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Hepatic steatosis associated with exposure to elvitegravir and raltegravir

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Dabigatran and The Risk of Staphylococcus Aureus Bacteremia- A Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of anal high-grade squamous intraepithelial lesions among renal transplant recipients compared with immunocompetent controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Proton pump inhibitor use is not strongly associated with SARS-CoV-2 related outcomes: A nationwide study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.

Original languageEnglish
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume73
Issue number3
Pages (from-to)e811-e814
ISSN1058-4838
DOIs
Publication statusPublished - Aug 2021

    Research areas

  • HIV Infections/complications, Humans, Prospective Studies, Quinolones/adverse effects, Raltegravir Potassium/adverse effects, NAFLD, ART, HIV

ID: 61877758